Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
518.00    4.00 (0.78%)
Bid:
514.00
Ask:
518.00
Spread: 4.00 (0.778%)
Market Cap: £856.33m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

31 Jan 2018 07:00

RNS Number : 4053D
Oakley Capital Investments Limited
31 January 2018
 

31 January 2018

 

Oakley Capital Investments Limited

 

Trading update for the twelve months ended 31 December 2017

 

Oakley Capital Investments Limited1 (AIM:OCI, the "Company"), which provides its shareholders with access to a portfolio of high quality companies through its investments in the Oakley Funds2, today announces a trading update for the 12 months ended 31 December 2017.

 

· NAV per share (unaudited) expected to be in the range of £2.43 - £2.45, representing an increase of at least 5% on December 2016 (£2.31)

· The Company has deployed £157.0m in the Oakley Funds and equity co-investments in 2017, during a period of significant investment

· The Company received £88.2m of distributions in the period

· Fund III closed at €800m in September 2017 of which the Company committed €326m

· Interim dividend of 2.25 pence, paid on 26 October 2017

 

Oakley Capital Limited ("Oakley Capital"), the Company's Investment Adviser, estimates that the Company's net asset value ("NAV"), which is subject to the completion of the 31 December 2017 audit of both the Oakley Funds and the Company, will be in the range of £498m to £502m, equating to a NAV per share of £2.43 to £2.45 (31 December 2016: £2.31).

 

Fund III has been active in deploying its capital and has invested €310.2m in five investments during the year, and completed another acquisition in January 2018 investing a further €84.6m. These portfolio companies represent investments in digital consumer, education and technology assets. The average entry EV/EBITDA multiple in Fund III, across all six assets, is currently 9.4x, reflecting the Investment Adviser's continued ability to access quality assets at attractive prices. OCI has an indirect interest in these portfolio companies through its 40.7% holding in Fund III.

 

During the year, the Company received £88.2m of distributions from the Oakley Funds and equity co-investments, relating to exits and refinancings.

 

The Company expects to report its annual results for 2017 on Thursday 15 March 2018.

 

 

- This announcement contains inside information -

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

Steven Tredget, Investor Relations

 

FTI Consulting LLP

+44 20 3727 1000

Edward Bridges / Stephanie Ellis

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Henry Freeman / Jill Li

 

 

1 About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

 

LEI Number: 213800KW6MZUK12CQ815

 

2 About Oakley Capital Private Equity L.P. ("Fund I"), Oakley Capital Private Equity II ("Fund II") and Oakley Capital Private Equity III ("Fund III") collectively the "Oakley Funds"

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II and Oakley Capital Private Equity III, are unlisted mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSDFEESFASEEF
Date   Source Headline
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 20253:16 pmRNSTransaction in Own Shares
24th Mar 20257:00 amRNSCapital Allocation Update
13th Mar 20257:00 amRNSFinal Results for the Year Ended 31 December 2024
26th Feb 20257:00 amRNSNotice of Results and Investor Presentation
5th Feb 20257:00 amRNSDirector Dealing
5th Feb 20257:00 amRNSDirector Dealing
3rd Feb 20257:00 amRNSDirector Dealing
29th Jan 20257:00 amRNSTrading update for the year ended 31 December 2024
20th Dec 202410:49 amRNSDirector Dealing
20th Dec 202410:48 amRNSDirector Dealing
19th Dec 20247:00 amRNSNorth Sails: Conversion of Equity
13th Dec 20247:00 amRNSDirector Dealing
13th Dec 20247:00 amRNSDirector Dealing
20th Nov 20247:00 amRNSOakley Capital invests in Konzept & Marketing
11th Nov 20247:00 amRNSHolding(s) in Company
8th Nov 20244:52 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSAppointment of Non-Executive Director
24th Oct 20247:00 amRNSOakley Capital agrees sale of Schülerhilfe to LLCP
23rd Oct 20247:00 amRNSTrading update for the 3 months ended 30 Sep 2024
21st Oct 20247:00 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSOakley Capital invests in Assured Data Protection
12th Sep 20247:00 amRNSInterim Results for the 6 months ended 30 June 24
2nd Sep 20247:00 amRNSOakley agrees sale of Ocean to Lloyds Register
29th Aug 20247:00 amRNSNotice of Results and Investor Presentation
13th Aug 20247:00 amRNSDirector Dealing
26th Jul 20247:00 amRNSDirector Dealing
24th Jul 20247:00 amRNSTrading Update for the 6 Months ended 30 June 2024
17th Jul 20243:52 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSOakley agrees sale of its investment in idealista
11th Jun 20247:00 amRNSOakley to invest in cybersecurity firm I-TRACING
7th Jun 20247:00 amRNSDirector Dealing
3rd Jun 20243:43 pmRNSResult of AGM
28th May 20247:00 amRNSOakley Capital invests in ProductLife Group
14th May 20247:00 amRNSOakley Capital invests in vitroconnect
8th May 20247:00 amRNSNotice of Annual General Meeting
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.